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Summary.-We have used the technique of human haemopoietic cell culture in agar
to study the peripheral blood and bone marrow colonyforming capacity of23 patients
with Phl+ve chronic granulocytic leukaemia (CGL) before and after treatment. In
comparison with normal controls the number of colony forming cells (CFC) is
moderately increased (about three-fold) in the bone marrow and enormously in-
creased in the peripheral blood of untreated patients. In the peripheral blood their
number in general is related to the total leucocyte count. In patients whose blood
counts have been restored to normal by the use of cytotoxic drugs the number of
CFC in the peripheral blood is very greatly reduced. In the marrow of treated
patients CFC are present in approximately normal numbers. When used as feeder
layer sto support the culture of normal bone marrow cells, the peripheral blood
leucocytes of untreated patients are a uniformly poor source of colony stimulating
factor (CSF) and fractionation experiments suggest that this is not due merely to a
relative scarcity of monocytes. After treatment the peripheral blood has normal
CSF activity and this is associated with the monocytic cell component. The last
data may be explained ineither oftwo ways: it ispossible thatrestoration ofthe blood
of patients with CGL to normal values removes a homeostatic factor suppressing
the formation of CSF by functionally normal monocytes, or alternatively treatment
with cytotoxic drugs leads to the replacement of defective monocytes by a population
of relatively normal CSF producing cells.
HAEMOPOIETIC cells from the bone
marrow and peripheral blood of normal
individuals proliferate in the agar semi-
solid culture system to form distinct
colonies ofup to 2000 leucocytes. Colony
formation appears to be wholly (or very
largely) dependent on the presence in the
culture system of a colony stimulating
factor (CSF) which, among other sources,
has been shown to originate from normal
peripheral bood leucocytes (Pike and
Robinson, 1970). In vitro colony forma-
tion by cells from patients with acute
myeloid leukaemia has been well charac-
terized by a number of workers (Paran
et al., 1970; Greenberg, Nichols and
Schrier, 1971; Brown and Carbone, 1971;
Moore, Williams and Metcalfe, 1973b) but
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less attention has been paid to colony
formation in chronic granulocytic leu-
kaemia (CGL). Such studies as have been
performed suggest that colony forming
cells (CFC) capable of giving rise to
morphologically normal colonies are
present in somewhat increased numbers
inthe bone marrow and in vastlyincreased
numbers in the peripheral blood of un-
treated patients; these CFC are all, or
almost all, descendants of a Phi-positive
leukaemic cell precursor (Shadduck and
Nankin, 1971; Chervenick et at., 1971;
Moore et al., 1973b).
The aims of the present study were to
relate the numbers of CFC in the peri-
pheral blood and bone marrow of patients
with CGL to the total leucocyte andJ. M. GOLDMAN, K. H. TH NG AND R. M. LOWENTHAL
differential counts in the peripheral blood
and to evaluate the production of CSF by
leucocytes and monocytes present in the
peripheral blood of patients before and
after treatment.
MATERIALS AND METHODS
We studied 23 patients in the chronic
phase of their disease. All patients had the
peripheral blood leucocyte " spectrum "
typical in CGL; the leucocyte alkaline
phosphatase level was low at the time of
diagnosis in each case and every patient
had the Ph' chromosomal anomaly. A small
number of the patients were studied on more
than one occasion and 2 patients were studied
again when they entered the acute blast cell
phase oftheir disease. The ratio of males to
females was 1 6: 1 and the mean age of the
patients studied was 43 years (range 11-68).
Approximately half the patients studied had
received no treatment while the others had
received a variety ofcytotoxic agents and one
patient was treated exclusively by leuca-
pheresis on an Aminco blood cell separator.
Peripheral blood and bone marrow obtained
from medical and technical staff and from
hospital patients without haematological or
neoplastic disease served as controls. Total
leucocyte counts were performed on the
peripheral blood obtained at the same time
as the blood and bone marrow to be used for
test purposes. Films were prepared and
stained with May-Griinwald-Giemsa and
differential counts made on 500 cells.
Preparation offeeder layers.-The method
of preparing feeder layers of peripheral blood
leucocytes was adapted from Pike and
Robinson (1970). 2 ml of dextran 6% w/v
was added to 20 ml of heparinized venous
blood and the erythrocytes were allowed to
sediment at room temperature for 60 min.
The leucocyte-rich supernatant was removed,
a total leucocyte count performed in a
haemacytometer and a differential count on a
May-Grtinwald-Giemsa stained film. The
leucocytes were then washed in McCoy's 5A
medium (Flow Laboratories, Scotland) and
finally incorporated into McCoy's 5A con-
taining 0-5% liquid agar (Bacto-agar, Difco,
USA) in a concentration of 1 x 106 nucleated
cells/ml. I ml of this solution was placed in
each ofa batch of30 mm petri dishes (Sterilin
Limited, Surrey, England) and incubated at
38°C in a humidified atmosphere of 7.5%
carbon dioxide. Feeder layers were normally
used within 48 h.
Collection and preparation of bone marrow
andperipheral bloodforculture.-Bonemarrow
was collected from patients with CGL and
control subjects and cultured by the method
of Pike and Robinson (1970) with minor
modifications. We routinely aspirated about
1 ml of bone marrow (and blood) from the
posterior iliac crest using a standard gauge
Salah needle and ejected it from the syringe
into a glass bottle containing McCoy's 5A
culture medium and heparin (20 i.u./ml).
Marrow fragments were dispersed ifnecessary
with a finely drawn Pasteur pipette and
erythrocytes allowed to sediment by gravity.
For cultures of peripheral blood, heparinized
venous blood was collected and allowed to
sediment in the same way. After approxi-
mately 2 h the leucocyte-rich supernatant
was removed and total nucleated cell counts
and differential counts were performed.
Cells were diluted and added to 0-3% agar
in a final concentration of 8 x 104 nucleated
cells/ml. When high numbers of CFC were
expected, additional dilutions to final con-
centrations of 4 and 2 x 104 cells/ml were
prepared. 1 ml of the final mixture was
inoculated over the appropriate feeder layer
and the plates were incubated at 38° in a
humidified atmosphere of 7.5% carbon
dioxide.
Leucocyte fractionation for preparation of
monocyte and neutrophil feeder layers.-20 ml
of heparinized venous blood was obtained
from patients with CGL and from normal
donors. The specimen was mixed and
centrifuged at 1000 g for 15 min at room
temperature. The cell-free supernatant was
removed and the packed erythrocytes and
leucocytes were reconstituted to their original
volume with McCoy's 5A medium. The
suspension was mixed thoroughly and then
laid gently over an Isopaque/Ficoll mixture
(B6yum, 1968) in a glass test tube. The
tube was then centrifuged at 1000 g for
15 min at room temperature and mononuclear
cells (monocytes and lymphocytes) were seen
to collect immediately below the McCoy's
medium, from where they could be harvested.
They were then washed twice in McCoy's 5A
medium, resuspended in a small volume of
medium and a total nucleated cell count was
performed. Films were made and stained
with May-Griinwald-Giemsa and differential
counts were performed. The mixture was
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adjusted to a final mononuclear cell concen-
tration of 3-4 x 106/ml which usually gave a
monocyte concentration not less than
5 x 105/ml and 1 ml of the suspension was
delivered into each culture dish. The dishes
were then incubated for 2 to 3 h at 38 C.
After this period non-adherent cells (mainly
lymphocytes) were removed by washing the
surface ofthe dish twice with culture medium
and the monocyte/macrophage nature of the
residual cells was confirmed by inspection
with an inverted microscope. Dishes that
appeared to have relatively few cells adherent
were discarded but no further cell count was
attempted at this stage. Thereafter, 1 ml of
heated mixture of McCoy's 5A medium with
0.5% agar was added to each dish and the
preparation allowed to set. The monocyte
feeder layers were incubated until use, usually
within 48 h.
For the preparation of feeder layers of
purified polymorphs, polymorphs and ery-
throcytes were collected from the bottom
of the centrifuge tube after decanting off the
Isopaque/Ficoll mixture. Erythrocytes and
polymorphs were pooled and reconstituted in
autologous plasma, 2 ml dextran was added
and the erythrocytes allowed to sediment at
room temperature for 2 h. The polymorph-
rich plasma was then harvested and the cells
were washed twice in McCoy's 5A medium.
A total leucocyte count was performed and a
stained film prepared for differential count-
ing. The polymorphs werethen incorporated
into 0-5% agar in a final concentration of
1 x 106/ml and 1 ml ofsuspension was added
to each petri dish and allowed to set. The
dishes were incubated until use.
Irradiation of feeder layers.-In order to
suppress the proliferation of CFC and cluster
forming cells, leucocyte, monocyte and
polymorph feeder layers were prepared in
the usual way and then exposed to 100, 500
or 1000 rad x-irradiation delivered by an
8 MeV linear accelerator at a rate of 100 rad/
min. Such feeder layers were then used for
peripheral blood or bone marrow culture
within a few hours of irradiation.
Interpretation of results.-Cultures of
haemopoietic cells were examined at intervals
after plating and were counted routinely after
10-12 days' incubation with the aid of a
Nikon stereoscopic microscope at 10-40 x
magnification. Collections of more than 50
cells were defined as colonies and smaller
collections were designated as clusters.
Colony size was graded on a scale of 1-5,
which represented an approximate range of
50-2000 cells. Peripheral blood or bone
marrow nucleated cells from patients with
CGL were usually cultured over feeder layers
obtained from 2 or 3 different normal donors
and 3, 4 or 5 replicate culture plates were set
up with each feeder layer. In general, feeder
layers from different normal donors gave
closely comparable results but occasionally
leucocytes from a particular donor un-
accountably stimulated relatively few
colonies; such results were then discounted.
When CGL donors provided cells for feeder
layers, the CSF production of these cells was
evaluated by the use of 2 or more normal
bone marrows and compared with results
obtained with the same bone marrows and
normal feeder layers. The results are ex-
pressed as the mean number ofcolonies in the
replicate plates in each experiment.
Individual colonies were selected at
varying periods of incubation and the cells
removed with a finely drawn Pasteur pipette.
They were then placed on a glass slide and
squashed between slide and cover slip with
digital pressure. These cells were stained
with aceto-orcein and examined by con-
ventional microscopy. Bandforms andpoly-
morphs could be clearly distinguished from
mononuclear cells by this technique.
RESULTS
In vitro colonyformation in cultures of
peripheral blood
Leucocytes were cultured from the
peripheral blood of 13 patients still in the
chronic phase of their disease who were
untreated or had received no recent treat-
ment (Table I). The mean number of
colonies counted per 8 X 104 nucleated
cells plated was 108-2 (±101-8) with a
range of 20-410. If only the patients
with peripheral blood leucocyte counts
above 100,000/1a1 are considered (which
excludes 3 of the 4 previously treated
patients), the mean number of colonies
was 131-1 (±106-1) with a range of 73-
410. The relationship of CFC in the
peripheral blood to the total peripheral
blood leucocyte count and to the absolute
number of blast cells in each culture plate
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TABLE I.-Colony Forming Capacity ofPeripheral Bloodfrom Patients with
Untreated CGL
Peripheral blood
Leucocytes
Treatment x 103/pl
None 504
None 353
None 331
NTR 310
None 252
None 200
None 195
None 190
None 149
None 102
NTR 82
NTR 56
NTR 34
Blasts
X 103/jd
30
15
10
9
27
4
4
2
10
2
1
2
0 3
212-2 9 0
Neutrophils
X 103/jd
181
154
160
59
137
94
128
148
60
63
30
38
23
98-1
Monocytes
x 103/pi
5
0
0 3
3
5
2
1
0
0 3
0
7
2
0 7
Mean colony
numbers per
8 x 104
nucleated cells
69*0 (72; 66)*
81-0 (80; 82)
410 (500; 320)
110 (120; 100)
210 (200; 200;
230)
95 (100; 90)
90 (100; 80)
73 (98; 48)
80-5 (76; 85)
92-7 (86; 100;
92)
46-0 (44; 48)
29-5 (38; 21)
20 (20)
2 -0 108 -2 (±101 -8)
Treatment: Four of the patients in this group had received treatment with cytotoxic drugs that ended
6 or more months previously (NTR = No treatment recently).
(1) These patients were studied again after treatment (see Table II).
* Numbers in brackets refer to the mean colony numbers with individual feeder layers.
TABLE II.-Colony Forming Capacity ofPeripheral Bloodfrom Patients with
Treated CGL
Patient Sex
Leb (2) M
Dib (2) F
Gee (2) M
Mean (± S.D.)
Age
67
51
57
58 3
Peripheral blood
Leucocytes Blasts Neutrophils Monocytes
Treatment x 103/jd X 103/pJ X 103/1l X 103/pJ
Bus. 96 1-0 76 2 9
Leuc. 93 2 2 8 56 3 8
Leuc. 268 2 7 110 2 7
152*4 2 2 80 7 3 1
Mean colony
numbers per
8 x 104
nucleated cells
49 7 (45; 47; 57)
54 7 (57; 55; 52)
50 0 (47; 53)
51 6 (±3*0)
F
F
F
M
32
39
37
57
41 -3
6-TG 4 0
Bus. 10-7
Cycl. 8-8
Bus. 12-5
9 0
0
0
0
0
0
2-8
8-4
6 -4
7 -2
6 -2
0 1 3 (2; 2;0)
1i0 Nil
0 8 Nil
0.5 Nil
06 03
(2) and (3): These patients were studied also before treatment (see Table I).
Leuc. represents treatment by leucapheresis on the Aminco blood cell separator.
6-TG, treatment with 6-thioguanine.
Bus., treatment with busulphan.
Cycl., treatment with a cyclical programme of cytotoxic drugs.
is shown in Fig. 1 and 2. There is an
apparent relationship between CFC num-
bers and the peripheral blood leucocyte
count and this assumes statistical signifi-
cance when re-plotted on a log-log basis-
in other words peripheral blood CFC
numbers increase exponentially as the
peripheral blood leucocyte count increases.
On the other hand, no correlation was
observed between peripheral blood colony
numbers and the number of blast cells
plated in each dish. The peripheral
blood of 2 patients was cultured again
after treatment exclusively by leuca-
pheresis (Table II). This treatment
reduced the total leucocyte count, and the
proportion of CFC in the peripheral blood
fell concomitantly. Peripheral blood was
Patient
Mau
Leb (1)
Woo
Law
Dib (1)
Tay
Gee (1)
Pur
Men
Buc (1)
Low
Jon
Yat
Sex
F
M
M
M
F
M
M
F
F
F
M
M
M
Age
59
67
57
58
51
68
57
51
29
32
24
32
53
49-1 Mean (±S.D.)
Buc (2)
Cur
Ben
Gee (3)
Mean
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* (410)
0 (210)
*(110)
* 0
0
0 a
0
A
A
S
A
0
0
A, A . I AL UAA I I I I I I
PERIPHERAL BLOOD LEUCOCYTE COUNT (cells/pl)
Fi(J. 1.- Coloiy forming capacity of peripheral blood leuicocytes from patients with CGL related to
peripheral blood leucocyte numbers.
The apparent relationship of CFC in the peripheral bloodl to peripheral blood( leucocyte counts
expressed on a log scale is not significant. If these results are re-plotted on a log-log scale, not
sho-wn here, the relationship is significanit (r = 0-725; P < 0 01). 0 = untreated patients,
* = treated patients.
cultured from 4 patients with total leuco-
cyte counts in the normal range following
treatment. Either very low numbers or
no colonies were observed (Table II),
which parallels the findings when the
peripheral blood of normal subjects is
cultured.
In vitro colonyformation in cultures of
bone nmarrow
Bone marrow was cultured from 15
patients in the chronic phase of CGL, 7 of
whom had received no previous treatment
of any kind (Table III). (One patient
(Ree) with a low leucocyte count before
treatment had a somewhat atypical peri-
pheral blood picture which was first
thought to represent transformation ofhis
disease. His subsequent response to
therapy was more consistent with the
chronic phase and the failure to grow
colonies from his marrow has not been
explained.) The mean number ofcolonies
per 8 x 104cells plated was 48K1 (+51-1)
with a range of 0-183. If only the un-
treated patients are considered, 6 of
whom had peripheral blood leucocyte
counts above 100,000/jtl, the mean number
of colonies was 75-3 (+61'2), which is
about 3 times as many as are obtained
when bone marrow from normal subjects
is cultured (27.6 (+10 2) colonies per
8 x 104 nucleated bone marrow cells
plated). The relationship of CFC in the
bone marrow to the peripheral blood
leucocyte count is shown in Fig. 3. Some
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NUMBER OF BLAST-CELLS PER 8 x 10 NUCLEATED CELLS PLATED
FiG. 2. Colony forming capacity of peripheral blood of patients with uncontrolled CGL related to
number of blast cells in each culture plate.
The scattergram fails to show a relationship between the number of blast cells plated and the
number of CFC cultured.
of our patients have been treated with
busulphan; others have received treat-
ment with 6-thioguanine or with the
cyclical use of 6 different cytotoxic drugs.
A comparison of bone marrow CFC
numbers in treated and untreated patients
with similar total peripheral blood leuco-
cyte counts suggested that chemotherapy
has no effect on CFC numbers independent
of its effects in reducing the peripheral
blood leucocyte count and by implication
the total granulocyte mass. In other
words, patients receiving treatment did
not consistently have fewer bone marrow
CFC than patients with comparable blood
counts who had never been treated or had
received no treatment recently. On the
other hand, we have observed falls in the
peripheral blood CFC numbers following
treatment by leucapheresis that are pro-
portionately greater than the correspond-
ing reductions in total peripheral blood
leucocyte numbers. This suggests that
leucapheresis may serve selectively to
remove CFC from the peripheral blood.
We cultured bone marrow from 2 patients
who had entered the acute blast cell phase
of their disease. In one case large num-
bers of small clusters were observed but
no normal colonies were seen. In the
other neither colonies nor clusters were
observed.
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TABLE III.-Colony Forming Capacity of Bone Marrow Cellsfrom Untreated
and Treated Patients with COL
Patient Sex
Dib F
Mau
Woo
Age Treatment
51 None
Peripheral blood
Leucocytes Blasts Neutrophils Mo
x 103/,Al x 103/pi X 103/pJ X
429 47 258
F 59 None 419 13 251
M 57 None 331 10 160
Gee
Dob
Buc (1)
Jon
Ree
Mean (+S.D.)
M
M
F
M
M
Hun F
Azi M
Mor M
Bol M
Cur F
Bla F
Hag M
Buc (2) F
Mean (±S.D.)
Mean of both
groups (± S.D.)
57
53
32
32
53
49 3
22
38
11
63
39
19
23
32
30 9
40 1
None
None
None
NTR
None
XRT
Bus.
Bus.
Cycl.
Bus.
6-TG
6-TG
6-TG
268
164
103
55
23
224 -0
176
63
14
13
10-7
8
7-7
4
37 0
130-5
2 -6
5
2
1 -6
0-2
10 -2
4
3
0
0
0
0
0
0
115
83
63
38
10
122 -3
119
46
9-5
10
8-5
6
4 0
2-8
25-7
74 0
Mean colony
- numbers per
nocytes 8 x 104
l03/,ul nucleated cells
4-2 183-2 (200; 200;
150)
0-2 52-5 (70; 35)
0 3 132 - 2 (200; 122;
114; 130; 95)
1-3 38 -5 (40 37)
3 50-1 (50; 53; 49)
0 33 4 (31; .3; 35)
2 112 (100; 124)
1-4 0(0;0)
1- 5 75 -3 (161-2)
7 32 (32)
1 38 -5 (44; 33)
3-2 5-3 (7; 6; 3)
0*3 23 -0 (22; 24)
1-0 17-5 (18; 17)
0-2 3-0 (2; 5; 2)
0-2 13-5 (15; 5)
004 355 (20; 42)
1 - 6 21 -0 (±13 -5)
1-55 48-1 (±51 1)
XRT, Radiotherapy. See Tables I and II for explanation of other abbreviations.
Morphology ofperipheral blood and bone
marrow colonies
No systematic study of the cellular
constituents of the observed colonies was
undertaken. Random colonies were,
however, frequently selected for examina-
tion of cell morphology. Up to the tenth
day of culture no colonies were observed
that did not have at least some identifiable
polymorphonuclear cells present. After
10 or more days' incubation, colonies were
occasionally observed in which mono-
nuclear cells predominated and few or no
polymorphs could be identified.
Colony stimulating factor production by
peripheral blood ofpatients with COL
Peripheral blood leucocytes from
patients with CGL were used to make
feeder layers. Leucocytes from the peri-
pheral blood of patients with raised
peripheral blood leucocyte counts regu-
larly failed to stimulate the growth of
CFC from the bone marrow of normal
donors and from the bone marrow and
peripheral blood of patients with CGL
(Fig. 4). A proportion of the cultures
showed the growth of very large numbers
(200-1000) of clusters of 3-10 cells in the
feeder layers and the feeder layer was
occasionally overgrown with a diffuse
" sheet " of cells. More frequently there
was growth neither in the feeder layer nor
in the overlay. When feeder layers were
prepared using leucocytes obtained from
the peripheral blood of patients with CGL
whose blood counts had been restored to
normal following treatment, normal colony
formation was observed with normal bone
marrow. Moreover, CGL leucocytes were
then as good as normal leucocytes in
supporting growth of CFC from CGL
peripheral blood and bone marrow.
In our early fractionation experiments
we routinely examined the CSF produc-
tion of feeder layers consisting almost
entirely (98%) of band forms and neutro-
phils. In numerous experiments in which
neutrophils from normal donors and from
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PERIPHERAL BLOOD LEUCOCYTE COUNT (cells/Iiil)
FIG. 3.-Colony forming capacity of bone marrow nucleated cells from patients with CGL related to
peripheral blood leucocyte numbers.
There is a clear relationship between peripheral blood leucocyte count ancl bone marrow CFC
numbers (r= 0-625; P <. 0.001). The shaded area represents colony numbers in normal bone
marrow. 0D untreate(l patients, A = treate(d patients.
patients with untreated and treated CGL
were used as feeder layers no colony forma-
tion was observed, or less than 3 colonies
per plate were grown; we concluded that
the mature granulocytic cells in the peri-
pheral blood do not contribute to CSF
production. Therefore, in later experi-
ments we abandoned the use of neutrophil
feeder layers. In contrast, feeder layers
prepared from mononuclear cells from
normal donors showed excellent CSF
activity; this activity was the same
whether or not we attempted to obtain a
pure monocyte preparation by washing off
the lymphocytes. We thus concluded
that CSF production by the peripheral
blood of normal donors is mainly a func-
tion of the monocytic cell component (or a
fraction of it).
We considered the possibility that the
poor CSF production by CGL peripheral
blood leucocytes might be due to a relative
scarcity of monocytes in the feeder layers.
(Monocytes were present, albeit in rela-
tively reduced numbers, in the peripheral
blood of all the patients with CGL whose
leucocytes were used as feeder layers.)
We therefore prepared feeder layers con-
sisting predominantly of monocytes and
showed that while monocytes obtained
from the peripheral blood of normal
donors were capable of stimulating colony
formation as w'ell as, or better than, un-
fractioned leucocyte feeder layers from
the same donor, feeder layers containing
comparable numbers of monocytes pre-
pared by fractionation of the peripheral
blood of patients with CGL and high leuco-
cyte counts failed to stimulate colony
formation. Monocyte feeder layers, how-
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FEEDER LAYER COMPOSITION
FIG. 4. CSF activity of feeder layers prepared from peripheral blood leucocytes of untreated andl
treated patients with CGL.
Feeder layers consistedl of (1) peripheral blood leucocytes (unfractionated), (2) leucocyte
fractions containing mainly monocytes, and (3) leucocyte fractions containing mainly neutrophils.
Cells for the feeder layers were obtained from untreated (0) and treated (-) patients with CGL
andl CSF activity was assayed by growth of CFC from normal bone marrow. The expected range
of CFC numbers using feeder layers obtained from normal donors is shown as the shaded area.
The horizontal bars represent means ± 1 standard deviation.
ever, prepared from the blood of patients
who had received adequate treatment and
whose leucocyte counts were within the
normal range stimulated normal colony
formation (Fig. 4).
One explanation for the lack of CSF
activity in the peripheral blood of un-
treated patients with CGL could be that
CFC already present in the feeder layers
are consuming CSF locally. Because irra-
diation using 100--1000 rad is known to
suppress colony formation without in-
hibiting the production of CSF, we per-
formed experiments in which batches of
feeder layers prepared from untreated
patients with CGL and control donors
were irradiated. The results of a repre-
sentative experiment are shown (TableIV).
TABLE IV.-CSF Activity ofFeeder Layers Exposed to Differing Doses of
Irradiation
Source of leucocytes
in feeder layers
CGL (untreated)
CGL (treated)
Normal subject
Mean colony numbers
per 8 x 104 normal human bone marrow cells
, - ~~~ ~ ~~A I
100 rad 500 rad 1000 rad No irradiation
Nil Nil Nil Nil
25-3 (±6 3) 33-5 (±8 5) 28-7 (±7-4) 33 5 (±4 7)
20-9 (±5 9) 25 7 (±10 1) 22-7 (±5 2) 27-5 (±10-0)
Figures are means from one experiment ±1 standard deviation.
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We concluded that if available CSF was
being consumed by CFC present in the
feeder layers, irradiation should block this
consumption and so allow its release to
support growth in the overlay. This was
not observed.
DISCUSSION
Our experiments were designed to test
two properties ofthe haemopoietic cells of
patients with CGL. First we examined
the colony forming capacity in agar of
peripheral blood and bone marrow cells
obtained from patients before and after
treatment; secondly, we examined the
capacity of peripheral blood leucocytes
from such patients to support the growth
in agar culture of normal human bone
marrow cells that is, their CSF activity.
Our experiments on the colony forming
capacity of cells from patients with CGL
have confirmed those of other workers,
and we have shown that peripheral blood
and bone marrow CFC numbers are
approximately proportional to the peri-
pheral blood leucocyte count. In con-
trast, our experiments on the CSF activity
of cells from patients with CGL have
yielded results that conflict with previous
reports; we have found that the leucocytes
of patients with untreated CGL lack CSF
activity while their CSF activity is in the
normal range when the peripheral blood
leucocyte count has been restored to
normal by treatment. We have also
shown that the CSF activity of the leuco-
cytes of the treated patients is associated
mainly with the monocytes, while the
monocytes of untreated patients are
inactive.
Colonyforming capacity of leucocytes in
CGL
The observation that CFC appear in
the peripheral blood in greatly increased
numbers in the untreated patient with
CGL is not new (Paran et al., 1970;
Moore et al., 1973b). It has been esti-
mated that the normal individual has
about 10 CFC per 106 nucleated cells in
the peripheral blood (Chervenick and
Boggs, 1971) but in untreated CGL this
number may rise to 1000-2000 and was
found to average 1350 in this study. In
addition, the number of cluster forming
cells in the peripheral blood, presumably
representing differentiated granulocytic
cells, may be extremely high (Moore et al.,
1973b) but such clusters are readily
distinguished from normal colonies and
have been ignored for the purpose of this
study. The relative increase in CFC in
the bone marrow of untreated patients
appears to be much less and only of the
order of two- or three-fold; the absolute
increase is, of course, much greater as the
total myeloid mass ofuntreated patients is
characteristically greatlyenlarged. When
the total leucocyte count has been restored
to normal and the blast cells have dis-
appeared from the peripheral blood, we
find that CFC are greatly reduced or
absent in the peripheral blood and appear
to be of approximately normal number in
the marrow. This agrees well with the
observations of other authors (Moore
et al., 1973b).
When we expressed CFC numbers as a
proportion of nucleated peripheral blood
or bone marrow cells plated, we observed a
correlation between CFC numbers on the
one hand and the total peripheral blood
leucocyte count of the CGL donor on the
other. Inasmuch as the total leucocyte
count gives some indication of the in-
creased total granulocyte mass of the
patient and thus of the extent of the
disease, this general correlation is perhaps
not surprising. What did surprise us
was the apparent log-log nature of the
relationship: for any given increase in
leucocyte count there was a proportion-
ately greater increase in circulating CFC
numbers. We doubt if this is explained
by a non-linear relationship between
observed colony numbers and CFC plated
since the effect of plating larger numbers
of CFC in each dish is more often to
reduce proportionately than to increase
numbers. More likely the observation is
real and advancing disease leads to the
circulation of proportionately greater
10IN VITRO COLONY FORMING CELLS
numbers of CFC. We also noted a
correlation between the peripheral blood
count and the number of C(FC present in
the bone marrow.
We might also have expected to have
shown a general relationship between the
number of peripheral blood blast cells
plated and the number of colonies ob-
served in a particular experiment. No
such correlation was observed. This
could be due to the inherent inaccuracy of
calculating the absolute number of blast
cells plated from a differential count
involving a rather low percentage of such
cells. Alternatively, it may mean that
there is no exact relationship between the
numbers of CFC and of blast cells present
in a given volume of blood. In this con-
text, it is of interest to note that the cell
tentatively identified as the haemopoietic
stem cell in certain primates (Dicke et al.,
1973) bears no morphological resemblance
to the myeloid blast cell of CGL.
Colony stirnulatiny activity of leucocytes in
CGL
Leucocytes obtained from the peri-
pheral blood ofnormal persons are in most
cases an excellent source of CSF and this
appears to originate from the monocytic
cell component (Golde and Cline, 1972;
Golde, Finley and Cline, 1972; Chervenick
and LoBuglio, 1972). WTe have now
shown that the peripheral blood leucocytes
of untreated patients with CGL are a very
poor source of CSF, and this observation
conflicts with the data of Moore who
reported uniformly good feeder layer
activity from patients with CGL (Moore,
Williams and Metcalf, 1 973a). The dis-
crepant findings could be explaine(d by
the fact that not all Moore's patients were
untreated or by the fact that the CFC
present in mouse bone marrow, used in
many of Moore's experiments, may differ
in CSF requirements from human CFC.
We found that peripheral blood leucocyte
feeder layers prepared from patients
whose peripheral blood counts had been
restored to normal by treatment had
normal CSF activity. This was a uniform
finding in our group of treated patients,
which included some whose peripheral
blood had been shown to be devoid of
CSF activity before treatment.
The finding that the peripheral blood
of untreated patients with CGL does not
provide CSF could be explained in a
number of ways. In the first place it is
possible that CSF is produced but con-
sumed locally by CFC and cluster forming
cells present in the feeder layer. WVe
believe that the finding that irradiated
CGL feeder layers, in which all cellular
proliferation has been suppressed, still fail
to produce CSF makes this explanation
unlikely. Secondly, our findings would
be adequately explained by high inhibitor
levels in the sera of untreated patients
with CGL but in fact very little autologous
plasma can be present in the feeder layers
after the leucocytes have been washed 2
or 3 times. Moreover, patients with CGL
have for the most part normal serum
inhibitor levels (Metcalf, 1973). Thirdly,
it is conceivable that CGL leucocyte
feeder layers produce little CSF because
of a relative scarcity of monocytes; some
monocytes were, however, present in all
our leucocyte feeder layers. In addition,
the number of monocytes obtained from
donors with CGL for use as purified
monocyte feeder layers was approxi-
mately comparable with that obtained
from normal donors; the former still
failed to show CSF activity. Purified
monocyte feeder layers obtained from
patients after treatment had normal CSF
activity. We are led to the conclusion
that the monocyte present in the peri-
pheral blood of untreated patients fails to
produce CSF either because its normal
CSF production has been " switched off"
or because it is intrinsically defective.
This last conclusion may be expanded
into two different hypotheses which are
presumably mutually exclusive. One ex-
planation hinges on the possible role of
CSF as a physiological regulator of peri-
pheral blood granulocyte numbers. In
other words, it is possible that the large
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number of granulocytes in the peripheral
blood in CGL leads to suppression of CSF
production by functionally normal mono-
cytes. (Presumably such suppression is
mediated in a manner distinct from the
inhibitors that have been identified in the
sera of normal people.) When tested in
vitro, these suppressed monocytes still fail
to produce CSF even though they are no
longer directly exposed to the large
granulocyte population. When treat-
ment reduces the total granulocyte mass
and the peripheral blood granulocyte
numbers, the negative feedback to the
monocyte is removed and CSF is again
produced. On this hypothesis the func-
tionally normal monocyte (i.e. a cell
sensitive to suppression by negative feed-
back from granulocytes and also capable
of producing CSF) might be a member of
the CGL clone of myeloid cells; however,
it is not yet known whether monocytes
in CGL carry the Ph' marker chromosome.
The alternative explanation implies that
there are two distinct monocyte popula-
tions, one intrinsically defective in CSF
production that predominates in the
peripheral blood before treatment, and
the other, indistinguishable from the
normal monocyte population, which pro-
liferates after treatment. The data neces-
sary to distinguish these two possibilities
are not yet available.
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